98%
921
2 minutes
20
Primary hypertension is the most common type of hypertension, with a complex and not fully understood pathogenesis. Insulin resistance (IR) is a metabolic abnormality that has been shown to be quite prevalent among patients with hypertension in existing literature. The triglyceride-glucose (TyG) index is a reliable indicator for assessing insulin resistance (IR). This study aims to evaluate the relationship between the TyG index at admission and all-cause mortality (ACM) in patients with severe primary hypertension, and to explore its role in predicting the future all-cause mortality risk in primary hypertension patients. This study employs a retrospective design to categorize all patients into four quartiles based on the TyG index. The Kaplan-Meier (K-M) method was utilized to estimate the survival curves for each group and to compare the survival outcomes across different quartiles. To assess the nonlinear relationship between the TyG index and prognosis, Cox proportional hazards regression models and restricted cubic splines (RCS) were applied, adjusting for potential confounders. Additionally, subgroup analyses were performed to conduct stratified analyses and interaction tests. Kaplan-Meier survival curve analysis showed that patients with higher TyG index levels had higher all-cause mortality rates at 30 days, 60 days, and 90 days post-admission. This indicates that a higher TyG index is associated with an increased risk of death in the short term. Additionally, multivariate Cox proportional hazards regression analysis revealed that an increased TyG index was significantly associated with all-cause mortality at 30 days, 60 days, and 90 days. Meanwhile, RCS analysis indicates that as the TyG index level increases, the hazard ratio (HR) shows a significant upward trend, suggesting a gradual increase in the risk of all-cause mortality. In summary, among patients with primary hypertension in the intensive care unit, elevated TyG levels are associated with an increased risk of short-term mortality.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11978879 | PMC |
http://dx.doi.org/10.1038/s41598-025-96202-4 | DOI Listing |
Diabetes Metab Syndr Obes
September 2025
Department of Nephrology, Wuyi County First People's Hospital, Jinhua City, Zhejiang Province, People's Republic of China.
Purpose: Metabolic syndrome (MetS) is linked to adverse outcomes in chronic diseases, but its impact on acute kidney injury (AKI) in elderly critically ill patients remains unclear. This study aimed to evaluate the association between MetS and 90-day mortality in this population.
Patients And Methods: A retrospective analysis included 774 elderly patients (≥65 years) with AKI admitted to the ICU from January 2022 to December 2023.
ERJ Open Res
September 2025
Department of Bioanalysis, Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
Background: In Belgium, age-standardised hospital admission and mortality rates for asthma and COPD are higher than the European average. Understanding the factors that lead to a hospitalised exacerbation and/or mortality is needed to optimise patient management.
Methods: Patients ≥18 years old obtaining two claims for drugs for obstructive airway diseases (ATC code R03) in 1 year between 2017 and 2022 were identified in Belgian nationwide claims-based data.
Eur Heart J Open
September 2025
Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan.
Aims: Intravenous tolvaptan sodium phosphate (IV-tolvaptan) is a novel aquaretic agent for acute decompensated heart failure (ADHF). This study evaluated its short-term effects and prognostic implications in clinical practice.
Methods And Results: In this retrospective cohort of 169 consecutive ADHF patients receiving IV-tolvaptan for the first time (mean age 76.
Eur Heart J Open
September 2025
Calderdale and Huddersfield NHS Foundation Trust, Acre St, Lindley, Huddersfield HD3 3EA, UK.
Aims: Cardiogenic shock remains a significant cause of mortality despite multiple advancements in medical interventions. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) provides crucial circulatory support but also increases left ventricular (LV) after-load, potentially worsening outcomes. Effective LV unloading strategies can enhance patient survival during VA-ECMO treatment.
View Article and Find Full Text PDFEur Heart J Open
September 2025
Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Gentofte Hospitalsvej 8, 2900 Hellerup, Denmark.
Aims: Atrial fibrillation (AF) may be associated with adverse influenza-related outcomes. We assessed the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) vs. standard-dose (SD-IIV) inactivated influenza vaccination against cardiovascular and all-cause hospitalizations and all-cause mortality according to history of AF.
View Article and Find Full Text PDF